Innoviva is a diversified biopharmaceutical company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics, and a portfolio of strategic investments in healthcare assets
| Website | http://www.inva.com/ |
| Employees | 18 (8 on RocketReach) |
| Address | 1350 Bayshore Hwy, Burlingame, California 94010, US |
| Phone | +1 650-238-9600 |
| Technologies |
JavaScript
,
HTML
,
PHP
+26 more
(view full list)
|
| Industry | Financial Services |
| Keywords | Royalty Streams, Diversified Portfolio, Passive Income Streams, Healthcare Assets, Long-Term Investments, Royalty Management, Healthcare Finance, Biotech Finance, Investment Portfolio, Asset Management, Financial Assets, Healthcare Portfolio, Diversified Holdings |
| Competitors | Chiesi Group, Viela Bio, Vertex Pharmaceuticals, UCB, AstraZeneca, Theravance Biopharma US, Inc., Mylan Belgium, Teva Pharmaceuticals, GSK, Regeneron +51 more (view full list) |
Looking for a particular Innoviva employee's phone or email?
Pavel Raifeld is the CEO of Innoviva.
8 people are employed at Innoviva.
Innoviva is based in Burlingame, California.